|
Princeton
Docket # 07-2399
Researchers
in the Molecular Biology Department at Princeton University have identified a
recurrent 8q22 genomic gain in poor-prognosis human breast cancers, which
harbors the metastasis gene Metadherin (MTDH). Genomic
gain of 8q22 elevates expression of MTDH,
which is overexpressed in more than 40% of breast cancers...
Published: 3/15/2018
|
Inventor(s): Yibin Kang, Guohong Hu
Keywords(s): Biotechnology/Pharmaceuticals, cancer/oncology, drug target, life science venture/early
Category(s): Biotechnology/Pharmaceuticals, Medical Devices/Diagnostics
|